A general view of the offices of Danish drugmaker Novo Nordisk in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little REFILE – CORRECTING LOCATION
A general view of the offices of Danish drugmaker Novo Nordisk in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little REFILE – CORRECTING LOCATION